Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Total Liabilities (2016 - 2022)

Edesa Biotech's Total Liabilities history spans 10 years, with the latest figure at $5.7 million for Q2 2022.

  • For Q2 2022, Total Liabilities rose 431.29% year-over-year to $5.7 million; the TTM value through Jun 2022 reached $5.7 million, up 431.29%, while the annual FY2021 figure was $1.5 million, 7.73% down from the prior year.
  • Total Liabilities for Q2 2022 was $5.7 million at Edesa Biotech, up from $3.4 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $8.9 million in Q2 2018 and bottomed at $183820.0 in Q4 2018.
  • The 5-year median for Total Liabilities is $1.5 million (2021), against an average of $2.9 million.
  • The largest annual shift saw Total Liabilities soared 2464.23% in 2018 before it plummeted 89.0% in 2020.
  • A 5-year view of Total Liabilities shows it stood at $183820.0 in 2018, then soared by 365.5% to $855676.0 in 2019, then grew by 20.76% to $1.0 million in 2020, then skyrocketed by 73.62% to $1.8 million in 2021, then surged by 217.92% to $5.7 million in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Total Liabilities are $5.7 million (Q2 2022), $3.4 million (Q1 2022), and $1.8 million (Q4 2021).